Psychedelic Commons
ExploreMethodsAbout
Share your data

Hatzipantelis CJ

Institute for Psychedelics and Neurotherapeutics, University of California, Davis, Davis, California 95616, United States.

5 papers · ORCID

View
ArticleMDMA

<i>R</i>-MDDMA is a Safer Analogue of MDMA with Therapeutic Potential.

Vargas MV, Hatzipantelis CJ, Dunlap LE +7

Europe PMC2026
View
ArticlePsilocybin

Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.

Hatzipantelis CJ, Liu M, Love A +13

Europe PMC2025
View
ArticleDMT

Indolethylamine <i>N</i>-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine Production.

Hatzipantelis CJ, Cameron LP, Liu M +8

Europe PMC2025
View
ArticleLSD

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential.

Tuck JR, Dunlap LE, Khatib YA +27

Europe PMC2025
View
ArticlePsilocybin

The Effects of Psychedelics on Neuronal Physiology.

Hatzipantelis CJ, Olson DE

Europe PMC2024
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.